Stocks and Investing
Stocks and Investing
Fri, November 11, 2022
[ Fri, Nov 11th 2022
] - WOPRAI
[ Fri, Nov 11th 2022
] - WOPRAI
[ Fri, Nov 11th 2022
] - WOPRAI
[ Fri, Nov 11th 2022
] - WOPRAI
[ Fri, Nov 11th 2022
] - WOPRAI
[ Fri, Nov 11th 2022
] - WOPRAI
[ Fri, Nov 11th 2022
] - WOPRAI
[ Fri, Nov 11th 2022
] - WOPRAI
[ Fri, Nov 11th 2022
] - WOPRAI
[ Fri, Nov 11th 2022
] - WOPRAI
[ Fri, Nov 11th 2022
] - WOPRAI
[ Fri, Nov 11th 2022
] - WOPRAI
[ Fri, Nov 11th 2022
] - WOPRAI
[ Fri, Nov 11th 2022
] - WOPRAI
[ Fri, Nov 11th 2022
] - WOPRAI
[ Fri, Nov 11th 2022
] - WOPRAI
[ Fri, Nov 11th 2022
] - WOPRAI
[ Fri, Nov 11th 2022
] - WOPRAI
[ Fri, Nov 11th 2022
] - WOPRAI
[ Fri, Nov 11th 2022
] - WOPRAI
Thu, November 10, 2022
[ Thu, Nov 10th 2022
] - WOPRAI
[ Thu, Nov 10th 2022
] - WOPRAI
[ Thu, Nov 10th 2022
] - WOPRAI
[ Thu, Nov 10th 2022
] - WOPRAI
[ Thu, Nov 10th 2022
] - WOPRAI
[ Thu, Nov 10th 2022
] - WOPRAI
[ Thu, Nov 10th 2022
] - WOPRAI
[ Thu, Nov 10th 2022
] - WOPRAI
[ Thu, Nov 10th 2022
] - WOPRAI
Chris Howerton Downgraded (APLS) to Hold and Decreased Target to $40 on, Nov 10th, 2022
Chris Howerton of Jefferies, Downgraded "Apellis Pharmaceuticals, Inc." (APLS) to Hold and Decreased Target from $70 to $40 on, Nov 10th, 2022.
Chris has made no other calls on APLS in the last 4 months.
There are 8 other peers that have a rating on APLS. Out of the 8 peers that are also analyzing APLS, 2 agree with Chris's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Tiago Fauth of "Credit Suisse" Maintained at Hold with Decreased Target to $43 on, Tuesday, November 8th, 2022
- Laura Chico of "Wedbush" Maintained at Hold with Increased Target to $67 on, Monday, September 12th, 2022
These are the ratings of the 6 analyists that currently disagree with Chris
- Steven Seedhouse of "Raymond James" Maintained at Strong Buy with Increased Target to $123 on, Tuesday, October 18th, 2022
- Annabel Samimy of "Stifel" Maintained at Strong Buy with Increased Target to $65 on, Thursday, September 8th, 2022
- Justin Kim of "Oppenheimer" Maintained at Buy with Increased Target to $78 on, Thursday, August 18th, 2022
- Madhu Kumar of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $102 on, Tuesday, August 9th, 2022
- Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Increased Target to $86 on, Wednesday, July 20th, 2022
- Douglas Tsao of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $75 on, Tuesday, July 19th, 2022
Contributing Sources